[The effect of the benzimidazole derivative AR-L 115 BS on the activities of myocardial adenylate cyclase and phosphodiesterase preparations (author's transl)].
The effect of benzimidazole derivative 2-[(2-methoxy-4-methylsulfinyl)phenyl]-1H-imidazol[4,5-b]pyridine (AR-L115 BS) on phosphodiesterase (PDE) and adenylate cyclase (AC) preparations from myocardial tissue was investigated in vitro. The following results were obtained: 1. AR-L 115 BS inhibits the PDE activity comparable to papaverine in a concentration-dependent and non-competitive way. Its inhibitory potency is about 40 times less if compared to papaverine since the Ki-values found are 315 and 7.9 mumol/l, respectively. The concentration of AR-L 115 BS producing a maximal positive inotropic effect on the isolated guinea-pig atrial preparation was shown to be 316 mumol/l, i.e., in the same concentration range as the biochemical findings. 2. The basal activity of myocardial AC preparations from reserpine pretreated guinea-pigs was not significantly altered in the presence of AR-L 115 BS concentrations ranging from 10 to 200 mumol/l. In contrast, the isoprenaline (1-100 mumol/l) stimulated AC was concentration-dependently inhibited already by 1 to 10 mumol/l AR-L 115 BS.